PMID- 28971480 OWN - NLM STAT- MEDLINE DCOM- 20171211 LR - 20180408 IS - 1097-0215 (Electronic) IS - 0020-7136 (Linking) VI - 142 IP - 3 DP - 2018 Feb 1 TI - Cancer survival in people with AIDS: A population-based study from Sao Paulo, Brazil. PG - 524-533 LID - 10.1002/ijc.31081 [doi] AB - Cancer survival among people with AIDS (PWA) has been described in developed countries, but there is lack of data from developing countries. The aim of this study was to evaluate survival after cancer diagnosis in PWA and compare it with people without AIDS (non-PWA) in Sao Paulo, Brazil. A probabilistic record linkage was carried out between the databases of the Population-based Cancer Registry of Sao Paulo (PBCR-SP) and the AIDS registry of SP (SINAN) to identify PWA who developed cancer. For comparison, non-PWA were frequency matched from the PBCR-SP by cancer site/type, sex, age, and period. Hazard ratio (HR) stratified by matching variables was estimated using a Cox proportional hazards model. A total of 1,294 PWA (20 patients with two primary site tumors) were included in the site/type-specific analyses. AIDS-defining cancers (ADC) comprised 51.9% of cases assessed. The all-cancer 5-year overall survival in PWA was 49.4% versus 72.7% in non-PWA (HR = 2.64; 95%CI = 2.39-2.91). Survival was impaired in PWA for both ADC (HR = 2.93; 95%CI = 2.49-3.45) and non-ADC (HR = 2.51; 95%CI = 2.21-2.84), including bladder (HR = 8.11; 95% CI = 2.09-31.52), lung (HR = 2.93; 95%CI = 1.97-4.36) and anal cancer (HR = 2.53; 95%CI = 1.63-3.94). These disparities were seen mainly in the first year after cancer diagnosis. The overall survival was significantly lower in PWA in comparison with non-PWA in Sao Paulo, as seen in high-income countries. Efforts to enhance early diagnosis and ensure proper cancer treatment in PWA should be emphasized. CI - (c) 2017 UICC. FAU - Tanaka, Luana F AU - Tanaka LF AUID- ORCID: 0000-0002-2086-7491 AD - Center for International Health, Medical Center of the University of Munich (LMU), Munich, Germany. AD - Department of Epidemiology, School of Public Health, University of Sao Paulo, Sao Paulo, Brazil. AD - Population-Based Cancer Registry of Sao Paulo, Department of Epidemiology, University of Sao Paulo, Sao Paulo, Brazil. FAU - Latorre, Maria do Rosario D O AU - Latorre MDRDO AD - Department of Epidemiology, School of Public Health, University of Sao Paulo, Sao Paulo, Brazil. AD - Population-Based Cancer Registry of Sao Paulo, Department of Epidemiology, University of Sao Paulo, Sao Paulo, Brazil. FAU - Gutierrez, Eliana B AU - Gutierrez EB AD - Municipal STD-AIDS Program, Secretaria Municipal de Saude, Sao Paulo, Brazil. FAU - Curado, Maria P AU - Curado MP AD - A. C. Camargo Cancer Center, Sao Paulo, Brazil. AD - International Prevention Research Institute, Lyon, France. FAU - Dal Maso, Luigino AU - Dal Maso L AUID- ORCID: 0000-0001-6163-200X AD - Cancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCS, Aviano, Italy. FAU - Herbinger, Karl-Heinz AU - Herbinger KH AD - Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany. FAU - Froeschl, Guenter AU - Froeschl G AD - Center for International Health, Medical Center of the University of Munich (LMU), Munich, Germany. AD - Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany. FAU - Heumann, Christian AU - Heumann C AD - Department of Statistics, University of Munich (LMU), Munich, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20171016 PL - United States TA - Int J Cancer JT - International journal of cancer JID - 0042124 SB - IM MH - Acquired Immunodeficiency Syndrome/*mortality/*pathology MH - Adult MH - Brazil/epidemiology MH - Developing Countries MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neoplasms/*mortality/*virology MH - Proportional Hazards Models MH - Registries OTO - NOTNLM OT - HIV/AIDS OT - cancer OT - epidemiology OT - medical record linkage OT - survival EDAT- 2017/10/04 06:00 MHDA- 2017/12/12 06:00 CRDT- 2017/10/04 06:00 PHST- 2017/04/25 00:00 [received] PHST- 2017/08/11 00:00 [revised] PHST- 2017/09/20 00:00 [accepted] PHST- 2017/10/04 06:00 [pubmed] PHST- 2017/12/12 06:00 [medline] PHST- 2017/10/04 06:00 [entrez] AID - 10.1002/ijc.31081 [doi] PST - ppublish SO - Int J Cancer. 2018 Feb 1;142(3):524-533. doi: 10.1002/ijc.31081. Epub 2017 Oct 16.